NCT05229991 - Once Daily Dosing of Lonafarnib Co-administered With Ritonavir for Treatment of Chronic Hepatitis D Virus Infection | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 15, 2021

Primary Completion Date

December 31, 2024

Study Completion Date

April 30, 2025

Conditions

Hepatitis D, Chronic

Interventions

DRUG

Lonafarnib

once-daily dosing of lonafarnib 50 mg with ritonavir 200 mg over a 48-week treatment period.

DRUG

Ritonavir

once-daily dosing of lonafarnib 50 mg with ritonavir 200 mg over a 48-week treatment period.

Trial Locations (3)

Soroka UMC, Beersheba

New Zealand Liver Transplant Unit, Auckland City Hospital, Auckland

Department of Gastroenterology and Hepatology, Koç University Medical School, Istanbul, Turkey, Istanbul